Trioxifene mesylate
| Code | Size | Price |
|---|
| TAR-T26295-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Trioxifene mesylate is an antiestrogen that suppresses growth hormone secretion.
CAS:
68307-81-3
Formula:
C60H64N2O8S
Molecular Weight:
973.24
Purity:
0.98
SMILES:
CS(O)(=O)=O.COc1ccc(cc1)C1=C(c2ccccc2CC1)c1cc(OCCN2CCCC2)ccc1C(=O)c1ccc(OCCN2CCCC2)cc1C1=C(CCc2ccccc12)c1ccc(OC)cc1
References
1. Lee RW, Buzdar AU, Blumenschein GR, Hortobagyi GN. Trioxifene mesylate in the treatment of advanced breast cancer. Cancer. 1986 Jan 1;57(1):40-3. PubMed PMID: 3940620.
2. Arafah B, Manni A, Pearson OH. Trioxifene mesylate (LY 133314): a new antiestrogen which inhibits growth hormone secretion in the rat. Eur J Cancer. 1980;Suppl 1:281-5. PubMed PMID: 7032941.
3. Witte RS, Pruitt B, Tormey DC, Moss S, Rose DP, Falkson G, Carbone PP, Ramirez G, Falkson H, Pretorius FJ. A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effects. Cancer. 1986 Jan 1;57(1):34-9. PubMed PMID: 3079661.
4. Neubauer BL, McNulty AM, Chedid M, Chen K, Goode RL, Johnson MA, Jones CD, Krishnan V, Lynch R, Osborne HE, Graff JR. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model. Cancer Res. 2003 Sep 15;63(18):6056-62. PubMed PMID: 14522935.